Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia Petroni

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Healthcare (Basel, Switzerland)|February 25, 2022
Health Management in Italian Prisons during COVID-19 Outbreak: A Focus on the Second and Third WaveRaimondo Vella, Gabriele Giuga, Giorgia Piizzi, et al.
Methods in Cell Biology|September 5, 2022
Quantification of cytosolic DNA species by immunofluorescence microscopy and automated image analysisAi Sato, Norma Bloy, Claudia Galassi, et al.
Legal Medicine (Tokyo, Japan)|February 27, 2026
Diagnostic pitfalls and forensic implications of hyperactive delirium with severe agitation: an Italian case seriesAnna Margari, Alessandro Tavone, Andrea Nicola Cardinale, et al.
Dentistry Journal|April 25, 2025
Histological Analysis of Biological Width and Collagen Fibers Orientation Around Screw-Less, Morse Taper, Hemispherical Base Abutments 8 and 16 Weeks After Implant Uncovering: An Observational Clinical TrialFabrizio Zaccheo, Giulia Petroni, Marco Tallarico, et al.
International Review of Psychiatry (Abingdon, England)|December 4, 2024
Clinical and legal issues of inmates' food refusal: the importance of decision-making capacity assessmentGiulia Petroni, Gabriele Mandarelli, Giovanna Parmigiani, et al.
Immunology|May 2, 2015
Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammationFrancesca Nencini, Sara Pratesi, Giulia Petroni, et al.
Frontiers in Oncology|September 26, 2025
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLCAlessandro Tubita, Sara Fancelli, Lorenzo Anela, et al.
Metabolites|January 27, 2026
Metabolomics Plasma Biomarkers Associated with the HRD Phenotype in Ovarian CancerAlessandro Tubita, Claudia De Angelis, Daniela Grasso, et al.
Heliyon|November 29, 2023
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patientsDaniele Lavacchi, Stefania Gelmini, Adele Calabri, et al.
British Journal of Cancer|November 22, 2017
The combined activation of K<sub>Ca</sub>3.1 and inhibition of K<sub>v</sub>11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cellsSerena Pillozzi, Massimo D'Amico, Gianluca Bartoli, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Healthcare (Basel, Switzerland)|February 25, 2022
Health Management in Italian Prisons during COVID-19 Outbreak: A Focus on the Second and Third WaveRaimondo Vella, Gabriele Giuga, Giorgia Piizzi, et al.
Methods in Cell Biology|September 5, 2022
Quantification of cytosolic DNA species by immunofluorescence microscopy and automated image analysisAi Sato, Norma Bloy, Claudia Galassi, et al.
Legal Medicine (Tokyo, Japan)|February 27, 2026
Diagnostic pitfalls and forensic implications of hyperactive delirium with severe agitation: an Italian case seriesAnna Margari, Alessandro Tavone, Andrea Nicola Cardinale, et al.
Dentistry Journal|April 25, 2025
Histological Analysis of Biological Width and Collagen Fibers Orientation Around Screw-Less, Morse Taper, Hemispherical Base Abutments 8 and 16 Weeks After Implant Uncovering: An Observational Clinical TrialFabrizio Zaccheo, Giulia Petroni, Marco Tallarico, et al.
International Review of Psychiatry (Abingdon, England)|December 4, 2024
Clinical and legal issues of inmates' food refusal: the importance of decision-making capacity assessmentGiulia Petroni, Gabriele Mandarelli, Giovanna Parmigiani, et al.
Immunology|May 2, 2015
Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammationFrancesca Nencini, Sara Pratesi, Giulia Petroni, et al.
Frontiers in Oncology|September 26, 2025
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLCAlessandro Tubita, Sara Fancelli, Lorenzo Anela, et al.
Metabolites|January 27, 2026
Metabolomics Plasma Biomarkers Associated with the HRD Phenotype in Ovarian CancerAlessandro Tubita, Claudia De Angelis, Daniela Grasso, et al.
Heliyon|November 29, 2023
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patientsDaniele Lavacchi, Stefania Gelmini, Adele Calabri, et al.
British Journal of Cancer|November 22, 2017
The combined activation of K<sub>Ca</sub>3.1 and inhibition of K<sub>v</sub>11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cellsSerena Pillozzi, Massimo D'Amico, Gianluca Bartoli, et al.
Pageof 8